북미의 산소발생기 시장 규모, 점유율, 동향 분석 : 제품별, 용도별, 기술별, 국가별, 부문별 예측(2025-2033년)

North America Oxygen Concentrators Market Summary

The North America oxygen concentrators market size was estimated at USD 1.99 billion in 2024 and is projected to reach USD 4.72 billion by 2033, growing at a CAGR of 10.0% from 2025 to 2033. The growth is attributed to an increase in the prevalence of respiratory conditions such as COPD, asthma, and sleep apnea.

According to the 2024 National Survey by Asthma Canada, over 4.6 million people in Canada are living with asthma, including 900,000 children under 19 and 800,000 adults over 65. Asthma is the third most prevalent chronic disease in the country, with an estimated 317 new diagnoses every day and around 250 deaths annually. In addition, advancements in respiratory technology are significantly supporting market growth.

Furthermore, favorable reimbursement policies have enhanced the attractiveness of the oxygen concentrators market in North America. For instance, in March 2024, a U.S. Congressman introduced the Supplemental Oxygen Access Reform (SOAR) Act to reform and improve access to supplementary oxygen for Medicare beneficiaries. These policies have increased the adoption of oxygen concentrators in the U.S. In addition, rising healthcare spending in the U.S. and Canada is driving the demand for effective diagnosis and treatment of respiratory diseases, thereby boosting the market for oxygen concentrators.

Initiatives by public and private authorities, such as the World Health Organization's distribution of oxygen concentrators and the efforts of associations like the American Lung Association, promote awareness of respiratory diseases. Market players also employ strategies such as acquisitions, collaborations, expansions, and new product launches to extend their product offerings and geographical reach. For instance, in June 2025, Inogen launched the Voxi 5 stationary oxygen concentrator, offering an affordable, durable, and quiet continuous flow oxygen therapy solution for long-term care patients in the US, enhancing home respiratory care accessibility. The device features a compact design, caster wheels for mobility, a 3-year sieve bed warranty, and advanced filtration technology.

North America Oxygen Concentrator Market Report Segmentation

This report forecasts volume & revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the North America oxygen concentrator market report on the basis of product, application, technology, and country.

• Products Outlook (Volume, Unit 000'; Revenue, USD Million, 2021 - 2033)
• Portable Medical Oxygen Concentrators
• Fixed Medical Oxygen Concentrators
• Application Outlook (Volume, Unit 000'; Revenue, USD Million, 2021 - 2033)
• Home Care
• Non-home Care
• Technology Outlook (Volume, Unit 000'; Revenue, USD Million, 2021 - 2033)
• Continuous Flow
• Pulse Flow
• Country Outlook (Volume, Unit 000'; Revenue, USD Million, 2021 - 2033)
• U.S
• Canada
• Mexico

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Products
  • 1.2.2. Application
  • 1.2.3. Technology
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Increase in the prevalence of respiratory conditions such as COPD, asthma, and sleep apnea.
  • 3.2.3. Growing adoption of home healthcare
  • 3.2.4. Technological advancements in oxygen concentrators
  • 3.2.5. Launch of new generation products and increasing business expansion
• 3.3. Market Restraint Analysis
• 3.4. High cost associated with oxygen concentrators
  • 3.4.1. Industry Opportunity Analysis
  • 3.4.2. Industry Challenge Analysis
  • 3.4.3. Case Studies
• 3.5. Business Environment Analysis
  • 3.5.1. Porter's Five Forces Analysis
  • 3.5.2. Supplier power
  • 3.5.3. Buyer power
  • 3.5.4. Substitution threat
  • 3.5.5. Threat of new entrant
  • 3.5.6. Competitive rivalry
• 3.6. PESTLE Analysis
  • 3.6.1. Political landscape
  • 3.6.2. Economic and Social landscape
  • 3.6.3. Technological landscape
  • 3.6.4. Environmental landscape
  • 3.6.5. Legal Landscape

Chapter 4. North America Oxygen Concentrator Systems Market: Products Estimates & Trend Analysis

• 4.1. Products Segment Dashboard
• 4.2. Products Market Share Movement Analysis, 2024 & 2033
• 4.3. Market Size & Forecasts and Trend Analysis, by Products, 2021 to 2033 (USD Million, Unit Volume 000')
• 4.4. Portable Medical Oxygen Concentrators
  • 4.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.4.2. Market estimates and forecast 2021 to 2033 (Unit Volume 000')
• 4.5. Fixed Medical Oxygen Concentrators
  • 4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.5.2. Market estimates and forecast 2021 to 2033 (Unit Volume 000')

Chapter 5. North America Oxygen Concentrator Market: Application Estimates & Trend Analysis

• 5.1. Application Segment Dashboard
• 5.2. Application Market Share Movement Analysis, 2024 & 2033
• 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Home Care
  • 5.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 5.5. Non-Home Care
  • 5.5.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. North America Oxygen Concentrator Market: Technology Estimates & Trend Analysis

• 6.1. Technology Segment Dashboard
• 6.2. Technology Market Share Movement Analysis, 2024 & 2033
• 6.3. Market Size & Forecasts and Trend Analysis, by Technology, 2021 to 2033 (USD Million)
• 6.4. Continuous flow
  • 6.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 6.5. Pulse Flow
  • 6.5.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. North America Oxygen Concentrator Market: Country Estimates & Trend Analysis

• 7.1. Country Market Dashboard
• 7.2. Country Market: Key Takeaways
  • 7.2.1. U.S.
    • 7.2.1.1. Key country dynamic
    • 7.2.1.2. Regulatory framework
    • 7.2.1.3. Competitive insights
    • 7.2.1.4. North America Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.2.2. Canada
    • 7.2.2.1. Key country dynamic
    • 7.2.2.2. Regulatory framework
    • 7.2.2.3. Competitive insights
    • 7.2.2.4. Canada Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.2.3. Mexico
    • 7.2.3.1. Key country dynamic
    • 7.2.3.2. Regulatory framework
    • 7.2.3.3. Competitive insights
    • 7.2.3.1. Mexico Oxygen Concentrator market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Share Analysis (2021-2024), by product
  • 8.2.1. Company Market share for Portable Medical Oxygen Concentrators
  • 8.2.2. Company Market share for Fixed Medical Oxygen Concentrators
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Respironics (a subsidiary of Koninklijke Philips N.V.) {Effective from January 25, 2024, Philips Respironics halted the sale of their POCs, with end of service scheduled for January 25, 2029.}
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial performance
    • 8.5.1.3. Products benchmarking
    • 8.5.1.4. Strategic initiatives
  • 8.5.2. Direct Supply
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial performance
    • 8.5.2.3. Products benchmarking
    • 8.5.2.4. Strategic initiatives
  • 8.5.3. GF Health Products, Inc.
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial performance
    • 8.5.3.3. Products benchmarking
    • 8.5.3.4. Strategic initiatives
  • 8.5.4. MedaCure Inc.
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial performance
    • 8.5.4.3. Products benchmarking
    • 8.5.4.4. Strategic initiatives
  • 8.5.5. Nidek Medical Products, Inc
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial performance
    • 8.5.5.3. Products benchmarking
    • 8.5.5.4. Strategic initiatives
  • 8.5.6. O2 Concepts
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial performance
    • 8.5.6.3. Products benchmarking
    • 8.5.6.4. Strategic initiatives
  • 8.5.7. React Health
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Products benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. CAIRE Inc. (Acquired by Niterra Co., Ltd. formerly known as NGK SPARK PLUG CO., LTD.)
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Products benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. DeVilbiss Healthcare (a subsidiary of Drive Medical)
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Products benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. GCE Group
    • 8.5.10.1. Overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Products benchmarking
  • 8.5.11. Compass Health Brands
    • 8.5.11.1. Overview
    • 8.5.11.2. Financial performance
    • 8.5.11.3. Products benchmarking